Tonix Pharmaceuticals Statistics Share Statistics Tonix Pharmaceuticals has 8.77M
shares outstanding. The number of shares has increased by 78.67%
in one year.
Shares Outstanding 8.77M Shares Change (YoY) 78.67% Shares Change (QoQ) 14.33% Owned by Institutions (%) 8.16% Shares Floating 8.76M Failed to Deliver (FTD) Shares 9,101 FTD / Avg. Volume 0.61%
Short Selling Information The latest short interest is 1.17M, so 13.39% of the outstanding
shares have been sold short.
Short Interest 1.17M Short % of Shares Out 13.39% Short % of Float 13.39% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.57 and the forward
PE ratio is -2.94.
Tonix Pharmaceuticals's PEG ratio is
0.01.
PE Ratio -0.57 Forward PE -2.94 PS Ratio 7.4 Forward PS 1.8 PB Ratio 0.53 P/FCF Ratio -1.22 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Tonix Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.5,
with a Debt / Equity ratio of 0.06.
Current Ratio 6.5 Quick Ratio 6.04 Debt / Equity 0.06 Debt / EBITDA -0.06 Debt / FCF -0.13 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $124.62K Profits Per Employee $-1.61M Employee Count 81 Asset Turnover 0.06 Inventory Turnover 0.92
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 87.69% in the
last 52 weeks. The beta is 1.87, so Tonix Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.87 52-Week Price Change 87.69% 50-Day Moving Average 37.81 200-Day Moving Average 28.6 Relative Strength Index (RSI) 36.22 Average Volume (20 Days) 1,495,806
Income Statement In the last 12 months, Tonix Pharmaceuticals had revenue of 10.09M
and earned -130.04M
in profits. Earnings per share was -176.6.
Revenue 10.09M Gross Profit 2.33M Operating Income -136.7M Net Income -130.04M EBITDA -126.61M EBIT -130.04M Earnings Per Share (EPS) -176.6
Full Income Statement Balance Sheet The company has 98.78M in cash and 8.12M in
debt, giving a net cash position of 90.66M.
Cash & Cash Equivalents 98.78M Total Debt 8.12M Net Cash 90.66M Retained Earnings -730.69M Total Assets 187.36M Working Capital 124.47M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -60.92M
and capital expenditures -120K, giving a free cash flow of -61.05M.
Operating Cash Flow -60.92M Capital Expenditures -120K Free Cash Flow -61.05M FCF Per Share -26.97
Full Cash Flow Statement Margins Gross margin is 23.07%, with operating and profit margins of -1354.28% and -1288.25%.
Gross Margin 23.07% Operating Margin -1354.28% Pretax Margin -1288.25% Profit Margin -1288.25% EBITDA Margin -1254.36% EBIT Margin -1354.28% FCF Margin -604.77%
Dividends & Yields TNXP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for TNXP is $70,
which is 183.4% higher than the current price. The consensus rating is "Buy".
Price Target $70 Price Target Difference 183.4% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 5, 2025. It was a
backward
split with a ratio of 1:100.
Last Split Date Feb 5, 2025 Split Type backward Split Ratio 1:100
Scores Altman Z-Score 7.33 Piotroski F-Score 3
